{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:47:00Z","timestamp":1783770420595,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018870","name":"Swedish Heart and Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20190266"],"award-info":[{"award-number":["20190266"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20200736"],"award-info":[{"award-number":["20200736"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20220210"],"award-info":[{"award-number":["20220210"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011727","name":"Stockholm l\u00e4ns landsting","doi-asserted-by":"publisher","award":["20180512"],"award-info":[{"award-number":["20180512"]}],"id":[{"id":"10.13039\/501100011727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011727","name":"Stockholm l\u00e4ns landsting","doi-asserted-by":"publisher","award":["2019003 1"],"award-info":[{"award-number":["2019003 1"]}],"id":[{"id":"10.13039\/501100011727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011727","name":"Stockholm l\u00e4ns landsting","doi-asserted-by":"publisher","award":["FoUI-97232 6"],"award-info":[{"award-number":["FoUI-97232 6"]}],"id":[{"id":"10.13039\/501100011727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011727","name":"Stockholm l\u00e4ns landsting","doi-asserted-by":"publisher","award":["FoUI-975446"],"award-info":[{"award-number":["FoUI-975446"]}],"id":[{"id":"10.13039\/501100011727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.atherosclerosis.2023.117439","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T21:08:05Z","timestamp":1703884085000},"page":"117439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia"],"prefix":"10.1016","volume":"389","author":[{"given":"Tigist","family":"Wodaje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Venkateshvaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"H\u00e4bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Zenlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gaylard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Angelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pernow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1230-6205","authenticated-orcid":false,"given":"Jonas","family":"Brinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117439_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2023.117439_bib2","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.jacc.2020.03.058","article-title":"Familial hypercholesterolemia: the most common monogenic disorder in humans","volume":"75","author":"Kastelein","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2023.117439_bib3","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"issue":"10312","key":"10.1016\/j.atherosclerosis.2023.117439_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(21)01122-3","article-title":"Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"398","author":"Vallejo-Vaz","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117439_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28030969","article-title":"Lipoprotein(a) in atherosclerotic diseases: from pathophysiology to diagnosis and treatment","volume":"28","author":"Lampsas","year":"2023","journal-title":"Molecules"},{"issue":"39","key":"10.1016\/j.atherosclerosis.2023.117439_bib6","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.atherosclerosis.2023.117439_bib7","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2023.02.050","article-title":"Lipoprotein(a), oxidized phospholipids, and coronary artery disease severity and outcomes","volume":"81","author":"Gilliland","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"18","key":"10.1016\/j.atherosclerosis.2023.117439_bib8","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2023.02.051","article-title":"Lipoprotein(a) and oxidized phospholipids: partners in crime or individual perpetrators in cardiovascular disease?","volume":"81","author":"Rader","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117439_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063346","article-title":"Pathophysiology of atherosclerosis","volume":"23","author":"Jebari-Benslaiman","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117439_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083850","article-title":"Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches","volume":"22","author":"Medina-Leyte","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2023.117439_bib11","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.atherosclerosis.2023.117439_bib12","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2174\/1381612824666180702154129","article-title":"Dyslipidemias and microcirculation","volume":"24","author":"Padr\u00f3","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.atherosclerosis.2023.117439_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.778762","article-title":"Imaging assessment of endothelial function: an index of cardiovascular health","volume":"9","author":"Minhas","year":"2022","journal-title":"Frontiers in cardiovascular medicine"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2023.117439_bib14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jcmg.2019.09.006","article-title":"Cardiovascular imaging techniques to assess microvascular dysfunction","volume":"13","author":"Mathew","year":"2020","journal-title":"JACC Cardiovascular imaging"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117439_bib15","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehq010","article-title":"Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events","volume":"31","author":"Rubinshtein","year":"2010","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117439_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/joim.13287","article-title":"Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia","volume":"290","author":"Benedek","year":"2021","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117439_bib17","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s12350-022-02974-x","article-title":"Definition and epidemiology of coronary microvascular disease","volume":"29","author":"Bradley","year":"2022","journal-title":"J. Nucl. Cardiol. : official publication of the American Society of Nuclear Cardiology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117439_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12947-016-0066-3","article-title":"Coronary flow velocity reserve by echocardiography: feasibility, reproducibility and agreement with PET in overweight and obese patients with stable and revascularized coronary artery disease","volume":"14","author":"Olsen","year":"2016","journal-title":"Cardiovasc. Ultrasound"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117439_bib19","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.jacc.2004.08.062","article-title":"Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia","volume":"44","author":"Bonetti","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117439_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166840","article-title":"The relationship between endothelial dysfunction and endothelial cell markers in peripheral arterial disease","volume":"11","author":"Igari","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117439_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"Marinescu","year":"2015","journal-title":"JACC Cardiovascular imaging"},{"issue":"37","key":"10.1016\/j.atherosclerosis.2023.117439_bib22","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117439_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13020193","article-title":"Coronary flow velocity reserve by echocardiography: beyond atherosclerotic disease","volume":"13","author":"Civieri","year":"2023","journal-title":"Diagnostics"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117439_bib24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0002-9149(02)02708-X","article-title":"Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension","volume":"90","author":"Galderisi","year":"2002","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117439_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092274","article-title":"Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options","volume":"10","author":"Salvatore","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.117439_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pcad.2014.12.002","article-title":"Regulation of coronary blood flow in health and ischemic heart disease","volume":"57","author":"Duncker","year":"2015","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117439_bib27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2174\/0929867325666180508100950","article-title":"Role of ox-LDL and LOX-1 in atherogenesis","volume":"26","author":"Kattoor","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117439_bib28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117439_bib29","doi-asserted-by":"crossref","first-page":"H175","DOI":"10.1152\/ajpheart.2000.278.1.H175","article-title":"oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles","volume":"278","author":"Hein","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117439_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/2047487318798059","article-title":"Combining cholesterol-lowering strategies with imaging data: a visible benefit?","volume":"26","author":"Koenig","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117439_bib31","first-page":"2032","article-title":"Effect of aging on myocardial perfusion reserve","volume":"36","author":"Uren","year":"1995","journal-title":"J. Nucl. Med. : official publication, Society of Nuclear Medicine"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2023.117439_bib32","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0735-1097(96)00376-2","article-title":"Coronary flow reserve is impaired in young men with familial hypercholesterolemia","volume":"28","author":"Pitk\u00e4nen","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117439_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15420\/ecr.2015.10.01.12","article-title":"Coronary flow velocity reserve assessment with transthoracic Doppler echocardiography","volume":"10","author":"Simova","year":"2015","journal-title":"European cardiology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117439_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2281.2001.00296.x","article-title":"Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography","volume":"21","author":"Saraste","year":"2001","journal-title":"Clinical physiology (Oxford, England)"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117439_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006427","article-title":"Quantitative assessment of coronary microvascular function: dynamic single-photon emission computed tomography, positron emission tomography, ultrasound, computed tomography, and magnetic resonance imaging","volume":"10","author":"Feher","year":"2017","journal-title":"Circulation Cardiovascular imaging"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117439_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jcmg.2016.02.003","article-title":"Imaging microvascular dysfunction and mechanisms for female-male differences in CAD","volume":"9","author":"Patel","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117439_bib37","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcin.2015.03.045","article-title":"Effect of sex differences on invasive measures of coronary microvascular dysfunction in patients with angina in the absence of obstructive coronary artery disease","volume":"8","author":"Kobayashi","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"issue":"39","key":"10.1016\/j.atherosclerosis.2023.117439_bib38","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1093\/eurheartj\/ehad472","article-title":"Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society","volume":"44","author":"Roeters van Lennep","year":"2023","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2023.117439_bib39","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-Year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"36","key":"10.1016\/j.atherosclerosis.2023.117439_bib40","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117439_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4250\/jcvi.2020.0244","article-title":"Effect of rosuvastatin on coronary flow reserve in hypertensive patients at cardiovascular risk","volume":"29","author":"Yang","year":"2021","journal-title":"Journal of cardiovascular imaging"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117439_bib42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S2213-8587(23)00156-0","article-title":"Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in The Netherlands: a 20-year follow-up study","volume":"11","author":"de Boer","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"45","key":"10.1016\/j.atherosclerosis.2023.117439_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.117439_bib44","first-page":"577","article-title":"Endothelial function testing and cardiovascular disease: focus on peripheral arterial tonometry","volume":"10","author":"Bruno","year":"2014","journal-title":"Vasc. Health Risk Manag."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023053601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023053601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:53:37Z","timestamp":1758156817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023053601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":44,"alternative-id":["S0021915023053601"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117439","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117439"}}